First Time Loading...

Entera Bio Ltd
NASDAQ:ENTX

Watchlist Manager
Entera Bio Ltd Logo
Entera Bio Ltd
NASDAQ:ENTX
Watchlist
Price: 2.51 USD 7.26% Market Closed
Updated: May 15, 2024

Entera Bio Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Entera Bio Ltd
Cost of Revenue Peer Comparison

Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Entera Bio Ltd
NASDAQ:ENTX
Cost of Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cost of Revenue
-$1.1m
CAGR 3-Years
28%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Cost of Revenue
-$87m
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
B
BioLine RX Ltd
TASE:BLRX
Cost of Revenue
-$3.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Cost of Revenue
-$9.4m
CAGR 3-Years
-110%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Entera Bio Ltd's Cost of Revenue?
Cost of Revenue
0 USD

Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Cost of Revenue amounts to 0 USD.